Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07142369Not ApplicableNot Yet Recruiting

Synovial Fluid Withdrawal or PRP Injection For Acute ACL Tears and Cytokines

Role: collaborator

NCT07135687Phase 4Not Yet Recruiting

Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction

Role: collaborator

NCT06171659Recruiting

FDG PET/MR Imaging of Peripheral Pain Generators

Role: collaborator

All 3 trials loaded